Works matching IS 02704137 AND DT 2022 AND VI 82 AND IP 13


Results: 10
    1

    Effect of upfront intensive therapy on oncological outcomes in older patients with high tumor burden metastatic castration‐sensitive prostate cancer: A multicenter retrospective study.

    Published in:
    Prostate, 2022, v. 82, n. 13, p. 1304, doi. 10.1002/pros.24404
    By:
    • Miura, Yuki;
    • Hatakeyama, Shingo;
    • Narita, Shintaro;
    • Kimura, Takahiro;
    • Hata, Kenichi;
    • Yanagisawa, Takafumi;
    • Tanaka, Toshikazu;
    • Ishi, Noritaka;
    • Kawamura, Sadafumi;
    • Hoshi, Senji;
    • Ishidoya, Shigeto;
    • Mitsuzuka, Koji;
    • Ito, Akihiro;
    • Tsuchiya, Norihiko;
    • Egawa, Shin;
    • Habuchi, Tomonori;
    • Ohyama, Chikara
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8

    The impact of enzalutamide on quality of life in men with metastatic hormone‐sensitive prostate cancer based on prior therapy, risk, and symptom subgroups.

    Published in:
    Prostate, 2022, v. 82, n. 13, p. 1237, doi. 10.1002/pros.24396
    By:
    • Stenzl, Arnulf;
    • Szmulewitz, Russell Z.;
    • Petrylak, Daniel;
    • Holzbeierlein, Jeffrey;
    • Villers, Arnauld;
    • Azad, Arun;
    • Alcaraz, Antonio;
    • Alekseev, Boris;
    • Iguchi, Taro;
    • Shore, Neal D.;
    • Gomez‐Veiga, Francisco;
    • Ivanescu, Cristina;
    • Rosbrook, Brad;
    • Ramaswamy, Krishnan;
    • Ganguli, Arijit;
    • Haas, Gabriel P.;
    • Armstrong, Andrew J.
    Publication type:
    Article
    9
    10

    Issue Information.

    Published in:
    Prostate, 2022, v. 82, n. 13, p. 1221, doi. 10.1002/pros.24163
    Publication type:
    Article